{"id":199003,"name":"CELLPHIRE, INC.","slug":"cellphire-inc","state":"MD","country":"United States of America","description":"Biotechnology Company","totalSpending":1200000,"filings":34,"yearlySpending":[{"year":2018,"income":90000},{"year":2019,"income":120000},{"year":2020,"income":150000},{"year":2021,"income":160000},{"year":2022,"income":160000},{"year":2023,"income":160000},{"year":2024,"income":200000},{"year":2025,"income":160000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"},{"code":"HCR","display":"Health Issues"}],"firms":["BURRELL INTERNATIONAL GROUP LLC"],"lobbyists":["DEBORAH BURRELL","KRISTIN STEVENS"],"govEntities":["Defense, Dept of (DOD)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["NDAA/Appropriations for Defense - US Army Medical Research.","NDAA/Appropriations for Defense - US Army Medical Research; Client services and products.","NDAA/Appropriations for Defense - US Army Medical Research; Client services and products\nS.2852 / HR 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018;","Blood supply and next generation blood products provisions related within the NDAA, Defense Appropriations and S2852/HR 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 201","Blood supply and next generation blood products provisions related within the NDAA, Defense Appropriations and S2852/HR 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 201"]}